Live Breaking News & Updates on Nasdaq First North Growth Market

Stay updated with breaking news from Nasdaq first north growth market. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Partner to iZafe Group Wins Procurement of Medication Robots Worth Approximately 3.7-4.3 MSEK

STOCKHOLM, SWEDEN / ACCESSWIRE / May 21, 2024 / iZafe Group (STO:IZAFE-B) iZafe Group AB ("iZafe Group") announces that their partner Zafe Care Systems AB ("Zafe") has been awarded a contract in a procurement ....

Skane Lan , David Bagares , Anders Segerstr , Medicinering Hemtj , Zafe Group , Zafe Care Systems , Kristianstad Municipality , Per La Fleur , Zafe Care , Chief Executive Officer , Life Science , Nasdaq First North Growth Market , Ihr Portfolio ,

Partner to iZafe Group Wins Procurement of Medication Robots Worth ...

Partner to iZafe Group Wins Procurement of Medication Robots Worth ...
pr-inside.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pr-inside.com Daily Mail and Mail on Sunday newspapers.

Skane Lan , David Bagares , Anders Segerstr , Medicinering Hemtj , News Network , Zafe Group , Zafe Care Systems , Kristianstad Municipality , Per La Fleur , Zafe Care , Chief Executive Officere Mail , Life Science , Nasdaq First North Growth Market ,

Spago Nanomedical Provides an Update on Tumorad-01 - Trial Proceeds ...

Spago Nanomedical Provides an Update on Tumorad-01 - Trial Proceeds ...
pr-inside.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pr-inside.com Daily Mail and Mail on Sunday newspapers.

Spago Nanomedical , F Spago Nanomedical , News Network , Data Monitoring Committee , Mats Hansen , Nasdaq First North Growth Market , Certified Adviser ,

Spago Nanomedical Provides an Update on Tumorad-01 - Trial Proceeds as Planned

LUND, SWEDEN / ACCESSWIRE / May 20, 2024 / Spago Nanomedical (STO:SPAGO.ST)(FRA:7UX.F) Spago Nanomedical AB (publ) announced today that both of the clinical sites in the phase I/IIa study Tumorad-01 are actively recruiting patients. So far two patients have been enrolled and successfully dosed. A third patient is en. ....

Spago Nanomedical , F Spago Nanomedical , Data Monitoring Committee , Mats Hansen , Nasdaq First North Growth Market , Certified Adviser ,